Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer

26 Nov 2022

Abstract excerpt

BACKGROUND: Breast cancer (BRCA) is one of the most common cancers in women worldwide and a leading cause of death from malignancy. This study was designed to identify a novel biomarker for prognosticating the survival of BRCA patients. METHODS: The prognostic potential of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) was assessed using RNA sequencing (RNA-seq) data from The Cancer Genome Atlas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Ferroptosis and cancer prognosis
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36551184
DOI: 10.3390/biom12121756

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EIF4G1 Is a Potential Prognostic Biomarker of Breast CancerPMID 36551184Read ↗

Identification and Validation of Immune-Related Gene Prognostic Signature for breast cancerSemantic proximity Read ↗

FREM1 Serves as a Novel Therapeutic Target in Breast Cancer through Basement Membrane-Based Prognostic Modeling with Integrated Bioinformatics and Experimental ValidationSemantic proximity Read ↗

High expression of eIF4E regulates immune cell infiltration and leads to poor prognosis in breast cancerSemantic proximity Read ↗

Identification of prognostic genes from the breast cancer microenvironmentSemantic proximity Read ↗

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancerSemantic proximity Read ↗

Development of a Novel Immune-Related Gene Prognostic Index for Breast CancerSemantic proximity Read ↗

Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancerSemantic proximity Read ↗

Interferon Regulatory Factor 4 (IRF4) is a Prognostic Marker and Related to Immune Infiltration in Breast and Colorectal CancersSemantic proximity Read ↗

CD1C is associated with Breast Cancer Prognosis and Immune InfiltratesSemantic proximity Read ↗

Construction and Validation of an Immune-related Gene Pairs Prognostic Model for Breast CancerSemantic proximity Read ↗

Prognostic value of immune-related genes identified basing on immune infiltration in breast cancerSemantic proximity Read ↗

Clinical implications and immunological features of iron metabolism-related gene prognostic signature in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.